Phase II clinical trials with time-to-event endpoints: Optimal two-stage designs with one-sample log-rank test
Publication
, Journal Article
Kwak, M; Jung, S-H
Published in: Statistics in Medicine
2013
Duke Scholars
Published In
Statistics in Medicine
EISSN
1097-0258
ISSN
0277-6715
Publication Date
2013
Related Subject Headings
- Statistics & Probability
- 4905 Statistics
- 4202 Epidemiology
- 1117 Public Health and Health Services
- 0104 Statistics
Citation
APA
Chicago
ICMJE
MLA
NLM
Kwak, M., & Jung, S.-H. (2013). Phase II clinical trials with time-to-event endpoints: Optimal two-stage designs with one-sample log-rank test. Statistics in Medicine.
Kwak, M., and S. -. H. Jung. “Phase II clinical trials with time-to-event endpoints: Optimal two-stage designs with one-sample log-rank test.” Statistics in Medicine, 2013.
Kwak M, Jung S-H. Phase II clinical trials with time-to-event endpoints: Optimal two-stage designs with one-sample log-rank test. Statistics in Medicine. 2013;
Kwak, M., and S. .. H. Jung. “Phase II clinical trials with time-to-event endpoints: Optimal two-stage designs with one-sample log-rank test.” Statistics in Medicine, 2013.
Kwak M, Jung S-H. Phase II clinical trials with time-to-event endpoints: Optimal two-stage designs with one-sample log-rank test. Statistics in Medicine. 2013;
Published In
Statistics in Medicine
EISSN
1097-0258
ISSN
0277-6715
Publication Date
2013
Related Subject Headings
- Statistics & Probability
- 4905 Statistics
- 4202 Epidemiology
- 1117 Public Health and Health Services
- 0104 Statistics